HIG
66
-2
WAT
59
-2
NVDA
65
-4
ETN
67
-2
MU
55
-4
O
50
2
R
67
-3
LRCX
50
-5
HCA
68
2
CB
57
3
MPC
44
2
A
48
-2
ICE
69
2
TRIP
40
-4
VFC
42
-3
REGN
31
-14
D
50
4
ADBE
60
3
KMB
51
-2
NFLX
76
3
HIG
66
-2
WAT
59
-2
NVDA
65
-4
ETN
67
-2
MU
55
-4
O
50
2
R
67
-3
LRCX
50
-5
HCA
68
2
CB
57
3
MPC
44
2
A
48
-2
ICE
69
2
TRIP
40
-4
VFC
42
-3
REGN
31
-14
D
50
4
ADBE
60
3
KMB
51
-2
NFLX
76
3
Financhill
Back

BridgeBio Pharma Stock Predictions

10 Best Stocks to Own in 2025

Get your copy now FREE!
Sell
40

BBIO
BridgeBio Pharma

Last Price:
$34.24
Seasonality Move:
24.04%

7 Day Trial

ALL ACCESS PASS

$ 7

10 stocks to buy for the next leg of this rally

Get the full list here FREE

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 37.3% based on the past 5 years of stock performance.
  • BridgeBio Pharma has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $34.25. The Score for BBIO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 37.3% based on the past 5 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
40
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
39.54
52-Week Low:
21.62

Prediction Charts

Market Cap:
6.5B
Price in USD:
34.25
Volume:
3M
Beta:
1.07

Technical Analysis

SMA50:
34.54
SMA100:
33.98
SMA200:
29.98
52-Wk Change:
18.72%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 34.25 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-12 34.54 35.68 36.11 34.26
May-13 34.73 33.26 34.84 33.21
May-14 33.33 33.66 34.05 32.90
May-15 33.74 33.74 34.02 33.24
May-16 33.82 33.84 34.16 33.57
May-19 33.43 33.69 33.90 32.70
May-20 33.46 33.71 34.44 33.03
May-21 33.36 32.84 33.68 32.51
May-22 32.72 32.97 33.25 32.39
May-23 32.48 33.34 33.43 32.30
May-27 33.93 33.10 33.93 32.97
May-28 33.14 32.26 33.40 32.16
May-29 32.56 33.37 33.39 31.77
May-30 33.09 34.25 34.73 32.37

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.22 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.